MICHAEL QUINN JOINS JDS THERAPEUTICS

MICHAEL QUINN JOINS JDS THERAPEUTICS

JDS Therapeutics, LLC Welcomes Michael Quinn as Director of Sales

PURCHASE, NY, April 16, 2012 – JDS Therapeutics, LLC, a marketer of proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals, announced today that Michael Quinn has joined JDS Therapeutics as Director of Sales.  Mr. Quinn will be responsible for leading the sales and sales training organizations of the Company.
Michael joined JDS Therapeutics in April 2012 and serves as the National Director of Sales. He has been part of the healthcare industry for 14 years beginning his career with Ortho-McNeil Pharmaceuticals, where he held multiple positions in sales and sales training in the women’s healthcare and urology specialties. In 2006, Michael joined JDS Pharmaceuticals as the Director of Sales Training where he was responsible for creating and implementing a new field sales training curriculum focused in the psychiatric specialty. When JDS Pharmaceuticals was acquired by Noven Pharmaceuticals in 2007, Michael remained with Noven as the Director of National Sales Training and Development before joining JDS Therapeutics.

Michael holds a Bachelor of Arts degree in History from Columbia University.

Commenting on the announcement, Michael Satow, President and CEO of JDS Therapeutics LLC, stated, “We are pleased to announce that Mike Quinn has joined JDS Therapeutics as Director of Sales. We are confident that Mike’s sales and sales training experience will be invaluable to JDS as we build our sales force in preparation for numerous product launches during the coming years.”  Mike’s background and experience are well-suited suited to lead the growth of our sales organization.”

About JDS Therapeutics:
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs. JDS Therapeutics owns more than 100 issued patents worldwide involving clinically active natural compounds. JDS was founded in 2011, by Phillip and Michael Satow, a father and son team whose previous company, JDS Pharmaceuticals was sold in 2007 to Noven Pharmaceuticals for $125 million.

For more information, please contact us.